This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Doxycycline

Read time: 1 mins
Marketing start date: 23 Nov 2024
...
 

Summary of product characteristics


Effective Time

20221013

Version

4

Spl Product Data Elements

Doxycycline Doxycycline DOXYCYCLINE DOXYCYCLINE ANHYDROUS CELLULOSE, MICROCRYSTALLINE CROSPOVIDONE D&C YELLOW NO. 10 FD&C BLUE NO. 2 FERRIC OXIDE YELLOW HYPROMELLOSES MAGNESIUM STEARATE POLYETHYLENE GLYCOL, UNSPECIFIED POLYSORBATE 80 SILICON DIOXIDE TITANIUM DIOXIDE PALE YELLOW biconvex, beveled edged 1121 Doxycycline Doxycycline DOXYCYCLINE DOXYCYCLINE ANHYDROUS CELLULOSE, MICROCRYSTALLINE CROSPOVIDONE FERRIC OXIDE RED FERRIC OXIDE YELLOW HYPROMELLOSES LACTOSE MONOHYDRATE MAGNESIUM STEARATE SILICON DIOXIDE TITANIUM DIOXIDE TRIETHYL CITRATE CREAMISH ORANGE biconvex, beveled edged 1122 Doxycycline Doxycycline DOXYCYCLINE DOXYCYCLINE ANHYDROUS CELLULOSE, MICROCRYSTALLINE CROSPOVIDONE D&C YELLOW NO. 10 FD&C RED NO. 40 FERRIC OXIDE YELLOW HYPROMELLOSES MAGNESIUM STEARATE POLYETHYLENE GLYCOL, UNSPECIFIED POLYSORBATE 80 SILICON DIOXIDE TITANIUM DIOXIDE LEMON YELLOW TO BUFF COLORED biconvex, beveled edged 1123 Doxycycline Doxycycline DOXYCYCLINE DOXYCYCLINE ANHYDROUS CELLULOSE, MICROCRYSTALLINE CROSPOVIDONE D&C YELLOW NO. 10 FERRIC OXIDE RED FERRIC OXIDE YELLOW HYPROMELLOSES LACTOSE MONOHYDRATE MAGNESIUM STEARATE SILICON DIOXIDE TITANIUM DIOXIDE TRIETHYL CITRATE DARK ORANGE TO CREAMISH ORANGE biconvex, beveled edged 1124

Application Number

ANDA209582

Brand Name

Doxycycline

Generic Name

Doxycycline

Product Ndc

70771-1008

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1006-1 Doxycycline Tablets, USP – 50 mg Rx only 100 Tablets NDC 70771-1007-1 Doxycycline Tablets, USP – 75 mg Rx only 100 Tablets NDC 70771-1008-7 Doxycycline Tablets, USP – 100 mg Rx only 50 Tablets NDC 70771-1009-1 Doxycycline Tablets, USP – 150 mg Rx only 100 Tablets Doxycycline Tablets USP, 50 mg Doxycycline Tablets USP, 75 mg Doxycycline Tablets USP, 100 mg Doxycycline Tablets USP, 150 mg

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.